Sound Income Strategies LLC Increases Holdings in Perrigo Company plc $PRGO

Sound Income Strategies LLC grew its holdings in shares of Perrigo Company plc (NYSE:PRGO) by 58.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,138,357 shares of the company’s stock after buying an additional 420,626 shares during the period. Sound Income Strategies LLC’s holdings in Perrigo were worth $17,110,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the business. Amundi lifted its holdings in Perrigo by 11.7% during the 1st quarter. Amundi now owns 5,292 shares of the company’s stock worth $148,000 after buying an additional 556 shares during the last quarter. Slocum Gordon & Co LLP lifted its holdings in Perrigo by 1.1% during the 3rd quarter. Slocum Gordon & Co LLP now owns 53,253 shares of the company’s stock worth $1,186,000 after buying an additional 602 shares during the last quarter. Kestra Investment Management LLC lifted its holdings in Perrigo by 57.1% during the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock worth $47,000 after buying an additional 642 shares during the last quarter. State of Wyoming lifted its holdings in Perrigo by 7.8% during the 3rd quarter. State of Wyoming now owns 8,988 shares of the company’s stock worth $200,000 after buying an additional 653 shares during the last quarter. Finally, First Citizens Bank & Trust Co. lifted its holdings in Perrigo by 4.7% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 17,323 shares of the company’s stock worth $386,000 after buying an additional 775 shares during the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Stock Down 2.8%

Perrigo stock opened at $10.55 on Tuesday. Perrigo Company plc has a fifty-two week low of $9.23 and a fifty-two week high of $28.43. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.63 and a current ratio of 2.76. The company has a market capitalization of $1.45 billion, a P/E ratio of -1.03, a PEG ratio of 1.27 and a beta of 0.47. The stock has a 50-day simple moving average of $12.23 and a 200-day simple moving average of $15.08.

Perrigo (NYSE:PRGO) last posted its earnings results on Thursday, February 26th. The company reported $0.77 earnings per share for the quarter, missing the consensus estimate of $0.80 by ($0.03). Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. During the same period in the previous year, the firm posted $0.93 earnings per share. The firm’s revenue for the quarter was down 2.5% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 24th. Stockholders of record on Monday, March 2nd were issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 11.0%. The ex-dividend date of this dividend was Monday, March 2nd. Perrigo’s payout ratio is presently -11.28%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Argus raised Perrigo to a “hold” rating in a report on Wednesday, January 14th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Perrigo in a report on Monday, December 22nd. Zacks Research downgraded Perrigo from a “hold” rating to a “strong sell” rating in a report on Friday, March 20th. JPMorgan Chase & Co. decreased their price target on Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a report on Monday, December 15th. Finally, Canaccord Genuity Group reduced their target price on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a report on Friday, February 27th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $19.33.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.